← FDA Drug Approvals (Drugs@FDA)
RANOLAZINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2025-02-04
Drug application
- FDA Application #
ANDA210407- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RANOLAZINE
- Generic name
- Ranolazine
- Active ingredients
- RANOLAZINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TORRENT
- First approval
- 2025-02-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown